Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06243068
NA

Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial

Sponsor: George Washington University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to compare two health system-based approaches for offering kidney failure treatment options to older patients with kidney failure, specifically, to ensure patients are actively involved in a shared decision making (SDM) process covering a full range of treatment choices and have meaningful access to that full range of choices. These include standard in-center or home dialysis as well as alternative treatment plans (ATPs): active medical care without dialysis, time-limited trial of dialysis, palliative dialysis, and deciding not to decide. Approach 1 - Educate and Engage: Nephrology practices encourage their patients to a) participate in a kidney disease education program providing a balanced presentation of all options including ATPs, b) use evidence-based patient decision aids that include ATPs, and c) engage in SDM with staff trained in communication skills and best practices. Approach 2 - Educate and Engage Plus Kidney Supportive Care Program: Nephrology practices add a primary palliative care program to support patients who choose ATPs and their families. The program provides care coordination, symptom management, advance care planning, and psychosocial support to supplement usual care from their nephrologist. To compare the two approaches, the investigators will conduct a repeated, cross-sectional stepped wedge cluster randomized trial involving 20-25 chronic kidney disease clinics at 8 practice organizations around the United States. Aim 1: Compare the effectiveness of Approaches 1 and 2 in a) increasing proportion of patients choosing ATP and b) reducing patient-reported decisional conflict about treatment. Aim 2: Compare the patient and family experience of ATP care between Approaches 1 and 2 in terms of quality of life, services used, and end of life (EOL) experience. Aim 2a will focus on experience while patients are receiving an ATP. Aim 2b will describe the EOL experience. Aim 3: Evaluate implementation of each approach through a mixed-methods design based on the expanded RE-AIM framework. For Aims 1 and 2, researchers will collect information by chart review and surveys with patients and caregivers. For Aim 3, clinic administrators, clinical providers, and staff will complete pre- and post-test surveys at the beginning and end of each training.

Official title: Improving Shared Decision-Making and Access to Non-Dialytic Treatment for People With Kidney Disease (The ExPAND Trial)

Key Details

Gender

All

Age Range

65 Years - Any

Study Type

INTERVENTIONAL

Enrollment

3000

Start Date

2024-11-13

Completion Date

2028-06-01

Last Updated

2025-07-18

Healthy Volunteers

No

Interventions

BEHAVIORAL

Educate and Engage

Nephrology practices implement a bundle in which they will encourage their patients to a) participate in a kidney disease education program providing a balanced presentation of all options including ATPs, b) use evidence-based patient decision aids that include ATPs, and c) engage in shared decision-making with staff who have been trained in communication skills and best practices.

BEHAVIORAL

Educate and Engage Plus Kidney Supportive Care Program

In addition to bundle described under "Educate and Engage," nephrology practices offer a systematic program integrating primary palliative care to support patients and their families who choose any ATP. The program closely follows patients and their families on ATP with care coordination, symptom management, advance care planning, and psychosocial support to supplement usual care from their nephrologist.

Locations (25)

UCSF/Zuckerberg San Francisco General Hospital and Trauma Center-Nephrology

San Francisco, California, United States

Medstar Washington Hospital Center

Washington D.C., District of Columbia, United States

Southeast Kidney Associates

Canton, Georgia, United States

Southeast Kidney Associates

East Point, Georgia, United States

St. Clair Nephrology

Shelby, Michigan, United States

The Rogosin Institute Manhattan Eat Dialysis

New York, New York, United States

Clinical Renal Associates

Exton, Pennsylvania, United States

Penn Presbyterian Medical Center

Philadelphia, Pennsylvania, United States

Perelman Center for Advanced Medicine

Philadelphia, Pennsylvania, United States

Renal Disease Research Institute

Dallas, Texas, United States

Renal Disease Research Institute

Fort Worth, Texas, United States

Renal Disease Research Institute

Garland, Texas, United States

Renal Disease Research Institute

Irving, Texas, United States

North Texas Kidney Disease Associates

Lewisville, Texas, United States

Renal Disease Research Institute

McKinney, Texas, United States

Renal Disease Research Institute

McKinney, Texas, United States

Renal Disease Research Institute

Mesquite, Texas, United States

North Texas Kidney Disease Associates

North Richland Hills, Texas, United States

North Texas Kidney Disease Associates

Plano, Texas, United States

Renal Disease Research Institute

Plano, Texas, United States

Virginia Nephrology Group

Alexandria, Virginia, United States

Virginia Nephrology Group

Arlington, Virginia, United States

Virginia Nephrology Group

Fairfax, Virginia, United States

West Virginia University Medicine

Fairmont, West Virginia, United States

West Virginia University Medicine

Morgantown, West Virginia, United States